← AbbVie
Episodes featuring AbbVie
50 episodes, newest first.
- Nov 20, 2026
Biotech weighs AI disruption against a stronger 2027 deal cycleBiotech HangoutNov 20, 2026 - Nov 17, 2026
Amazon backs AI expansion as NVIDIA leadership risk tests the tradeHalftime ReportNov 17, 2026 - Nov 16, 2026
Prepare for a crash without abandoning the marketRich Habits PodcastNov 16, 2026 - Nov 13, 2026
Biotech launches expose the gap between forecasts and adoptionBiotech HangoutNov 13, 2026 - Nov 13, 2026
Scarce capital creates openings in overlooked ASX small capsThe Rules of InvestingNov 13, 2026 - Nov 11, 2026
CoreWeave tests whether AI stocks can sustain their reboundHalftime ReportNov 11, 2026 - Nov 9, 2026
AbbVie builds a risk-managed neuroscience portfolioBusiness Of BiotechNov 9, 2026 - Nov 5, 2026
Solvonis expands ketamine patent into behavioral addictionsThe Sunday RoastNov 5, 2026 - Nov 4, 2026
Markets rally as Democrats take CongressCNBC's "Fast Money"Nov 4, 2026 - Nov 4, 2026
AI spending strains cash flow as AMD raises the stakesCNBC's "Fast Money"Nov 4, 2026 - Oct 30, 2026
AI financing fears deepen technology sell-offClosing BellOct 30, 2026 - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026 - Oct 30, 2026
Amazon earnings test the AI spending boomHalftime ReportOct 30, 2026 - Oct 29, 2026
Big Tech earnings expose a higher bar for the AI tradeClosing BellOct 29, 2026 - Oct 27, 2026
Anthropic’s filing tests the durability of the AI tradeThe Compound and FriendsOct 27, 2026 - Oct 26, 2026
Anthropic filing puts AI’s capital demands under the market’s microscopeClosing BellOct 26, 2026 - Oct 26, 2026
Anthropic IPO tests whether AI spending can deliver durable growthHalftime ReportOct 26, 2026 - Oct 22, 2026
AI Sell-Off Tests Tech’s Growth StoryCNBC's "Fast Money"Oct 22, 2026 - Oct 22, 2026
AI spending faces a harsher test as capital tightensHalftime ReportOct 22, 2026 - Oct 19, 2026
Bostwick argues CNS breakthroughs need better biology and deliveryBusiness Of BiotechOct 19, 2026 - Oct 16, 2026
Biotech selloff tests valuations as clinical bets advanceBiotech HangoutOct 16, 2026 - Oct 16, 2026
FDA turnover and ESMO put biotech catalysts under scrutinyBiotech Bulls & BreakthroughsOct 16, 2026 - Oct 16, 2026
AI concentration meets higher yields as investors rotateHalftime ReportOct 16, 2026 - Oct 14, 2026
AI infrastructure trade collides with debt, rates and weaker risk appetiteClosing BellOct 14, 2026